Question 1

What is classic dopamine transporter deficiency syndrome?

Accepted Answer

Classic dopamine transporter deficiency syndrome is an inherited neurological disorder that presents in early infancy. It is caused by pathogenic variants in the SLC6A3 gene, which impairs the function of the dopamine transporter, a key protein involved in regulating brain dopamine levels. Affected infants typically exhibit early signs such as neonatal distress, irritability, feeding difficulties, and motor developmental delays. Although precise prevalence data are not available, the condition is recognized as a rare inherited disorder.

Question 2

What are the symptoms of classic dopamine transporter deficiency syndrome?

Accepted Answer

Affected individuals typically present with a range of neurological and motor difficulties. Early clinical features include delayed gross motor development, hypertonia, a hypomimic face, oromandibular dystonia, and global developmental delay, with increased cerebrospinal fluid homovanillic acid concentration reliably observed. As the disease progresses, many children may develop additional symptoms such as rigidity, bradykinesia, tremor, and parkinsonism, while other features like hyperkinetic movements, axial hypotonia, cogwheel rigidity, chorea, dyskinesia, ocular flutter, or oculogyric crisis occur in a subset of cases. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes classic dopamine transporter deficiency syndrome?

Accepted Answer

The condition is caused by pathogenic variants in the SLC6A3 gene, which encodes the dopamine transporter. This protein plays a critical role in the reuptake of dopamine from neuronal synapses, thus regulating its levels in the brain. In classic dopamine transporter deficiency syndrome, both copies of the gene are affected, consistent with its autosomal recessive inheritance. This means that each child of carrier parents has a one in four chance of being affected, and genetic counseling is recommended for families to understand the implications for future pregnancies. Associated genes include SLC6A3.

Question 4

How is classic dopamine transporter deficiency syndrome inherited?

Accepted Answer

classic dopamine transporter deficiency syndrome follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is classic dopamine transporter deficiency syndrome diagnosed?

Accepted Answer

The definitive diagnosis is established through molecular genetic testing that identifies pathogenic variants in the SLC6A3 gene. In addition to genetic testing, clinical evaluation—including the assessment of developmental history, characteristic motor findings, and laboratory measurements such as increased CSF homovanillic acid concentration—is crucial. Because several features can be seen in other neurological conditions, genetic confirmation is essential to distinguish this disorder from others with overlapping symptoms.

Question 6

Are there treatments for classic dopamine transporter deficiency syndrome?

Accepted Answer

Currently, management focuses on supportive care and symptom management, as there are no treatments specifically approved for classic dopamine transporter deficiency syndrome. A multidisciplinary care approach is essential, involving specialists who can address the neurological, developmental, and motor aspects of the condition. In addition, regular surveillance is an important part of long-term care to monitor for emerging complications. Patients and their families are encouraged to discuss treatment options with their healthcare team and to consider genetic counseling to better understand the condition and plan for the future.

Question 7

What complications can arise from classic dopamine transporter deficiency syndrome?

Accepted Answer

Complications from classic dopamine transporter deficiency syndrome can include persistent motor difficulties and developmental delays. As the disease progresses, some children may develop symptoms like rigidity, bradykinesia, and tremor. Regular monitoring is important to identify and manage these complications as they arise.

Question 8

How does classic dopamine transporter deficiency syndrome affect daily life for patients and families?

Accepted Answer

Living with classic dopamine transporter deficiency syndrome can be challenging for both patients and their families. Daily life may involve managing motor difficulties and developmental delays, which can affect activities like feeding and mobility. Supportive care and a multidisciplinary approach can help improve quality of life and assist families in navigating these challenges.

Question 9

What is the prognosis for individuals with classic dopamine transporter deficiency syndrome?

Accepted Answer

The prognosis for individuals with classic dopamine transporter deficiency syndrome varies widely based on symptom severity and age at diagnosis. While many face lifelong challenges, some may experience stabilization of symptoms after early childhood. With proper care and support, families can see improvements in quality of life over time.

Question 10

What specialists should we consult for managing classic dopamine transporter deficiency syndrome?

Accepted Answer

For managing classic dopamine transporter deficiency syndrome, it is important to involve a multidisciplinary team of specialists. This may include neurologists, developmental pediatricians, and physical therapists who can address the neurological and motor aspects of the condition. Regular consultations with these specialists can help ensure comprehensive care and support for the patient.

Organ System	Phenotype Count	Example Features
Brain and nerves	12	Slowness of movement (bradykinesia), Dystonia, Muscle stiffness (rigidity)
Digestive system	3	Gastroesophageal reflux, Constipation, Feeding difficulties
Muscles	2	Axial hypotonia, Delayed gross motor development
Lab test results	1	Increased CSF homovanillic acid concentration
Head and neck	1	Hypomimic face
Arms and legs	1	Limb dystonia
Eyes	1	Ocular flutter

Gene	Disorder	MOI	Comment
Aromatic L-amino acid decarboxylase deficiency	AR	Clinical features assoc w/SLC6A3-related DTDS (progressive parkinsonism-dystonia, eye movement disorder, axial hypotonia, delayed motor development) may be similar to those seen in other neurotransmitter disorders.1,2	—

System/Concern	Evaluation	Comment
Movement disorder	Neurologic assessment of the movement disorder	Orolingual dyskinesia
Gastrointestinal	Assess for vomiting, GERD, constipation.

System/Concern	Evaluation	Frequency
Movement disorder	Neurologic assessment of the movement disorder	At each visit, every 6-12 mos Orolingual dyskinesia
Ophthalmology	Assessment for eye movement disorders refractive error to maximize visual function	Every 12 mos Orthopedic
Gastrointestinal	Assess for vomiting, GERD, constipation.	At each visit
Neuropsychiatric	Assessment for ADHD	At each visit in persons w/atypical later-onset SLC6A3-related DTDS ADHD = attention-deficit/hyperactivity disorder; ADL = activities of daily living; DTDS = dopamine transporter deficiency syndrome; GERD = gastroesophageal reflux disease; OT = occupational therapy; PT = physical therapy

Kisho

classic dopamine transporter deficiency syndrome

Overview

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Clinical Presentation

Clinical Guidance

Explore clinical features

Genetic Landscape

Diagnosis

Diagnostic Criteria

Suggestive Findings

Clinical Findings

Differential Diagnosis

Treatment

Orphan Drug Designations

Management Guidelines

Clinical Guidance

Clinical Trials

Prognosis

Surveillance Guidelines

Research Landscape

Recent Publications

classic dopamine transporter deficiency syndrome

Overview

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is classic dopamine transporter deficiency syndrome?

What are the symptoms of classic dopamine transporter deficiency syndrome?

What causes classic dopamine transporter deficiency syndrome?

How is classic dopamine transporter deficiency syndrome inherited?

How is classic dopamine transporter deficiency syndrome diagnosed?

Are there treatments for classic dopamine transporter deficiency syndrome?

What complications can arise from classic dopamine transporter deficiency syndrome?

How does classic dopamine transporter deficiency syndrome affect daily life for patients and families?

What is the prognosis for individuals with classic dopamine transporter deficiency syndrome?

What specialists should we consult for managing classic dopamine transporter deficiency syndrome?

Clinical Presentation

Clinical Guidance

Explore clinical features

Genetic Landscape

Diagnosis

Diagnostic Criteria

Suggestive Findings

Clinical Findings

Differential Diagnosis

Treatment

Orphan Drug Designations

Management Guidelines

Clinical Guidance

Clinical Trials

Prognosis

Surveillance Guidelines

Research Landscape

Recent Publications